Brainstorm cell therapeutics to present at biotech showcase™ 2022

New york, jan. 4, 2022 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced today that ralph kern, m.d. mhsc, president and chief medical officer of brainstorm cell therapeutics, will provide a corporate and clinical overview at biotech showcase™ 2022, to be held virtually january 10-12 and 17-18, 2022.
BCLI Ratings Summary
BCLI Quant Ranking